首页> 外国专利> D-14 double bond steroids replacing 13 and 14 sites, androgenica and progena activities

D-14 double bond steroids replacing 13 and 14 sites, androgenica and progena activities

机译:D-14双键类固醇替代13和14位,雄激素和后代活动

摘要

It refers to a kind of sterol compound, its double delta 14, substituting for the positions at the 15th and 16th preparation level: R1 is O, (h, H),(H OR)NOR; R IS H, C1-C6-ALKYL, C1-C6-ACIL; R2 AND R3 ARE H, C1-C4 ALKYL, C2-C4 ALKYNYL; R4 IS C1-C2 ALKYL; R5 IS H, C1-C4 ALKYL, C2-C4 ALKYNYL; R6 AND R7 ARE H, C1-C4 ALKYL, C2-C4 ALKYLN; R8 IS H, ACILO C1-C15. THEY ARE PREFERRED COMPOUNDS (7a, 17b) -17-HIDROXI-7,15-DIMETILESTRA-4,14-DIEN-3-ONA; (7a, 16a, 17ß) -17-HIDROXI-7,16-DIMETILESTRA-4,14-DIEN-3-ONA. ALSO REFERS TO USE WITH AN ANDROGEN THAT IS NOT 7a-REDUCABLE AS 7a-METHYL NANDROLONE. THE COMPOUND MAY BE USEFUL FOR THE TREATMENT OF ANDROGENIC INSUFFICIENCY, PROGESTAGENIC AS A MALE OR FEMALE HORMONAL REPLACEMENT THERAPY OR AS A MALE CONTRACEPTIVE
机译:它是指一种固醇化合物,其双δ14取代了第15和第16制备级的位置:R1为O,(h,H),(H OR)NOR; R是H,C1-C6-烷基,C1-C6-ACIL; R2和R3为H,C1-C4烷基,C2-C4烷基; R4是C1-C2烷基; R5是H,C1-C4烷基,C2-C4烷基; R6和R7为H,C1-C4烷基,C2-C4烷基; R8是H,ACILO C1-C15。它们是优选的化合物(7a,17b)-17-HIDROXI-7,15-DIMETILESTRA-4,14-DIEN-3-ONA; (7a,16a,17ß)-17-HIDROXI-7,16-DIMETILESTRA-4,14-DIEN-3-ONA。还建议将不可还原为7a的雄激素与7a-甲基NANDROLON一起使用。该化合物可用于治疗雄激素不足,激素作为男性或女性荷尔蒙替代疗法或男性避孕药

著录项

  • 公开/公告号PE20020752A1

    专利类型

  • 公开/公告日2002-08-22

    原文格式PDF

  • 申请/专利权人 AKZO NOBEL N.V.;

    申请/专利号PE2001001255

  • 申请日2001-12-14

  • 分类号C07J1/00;A61K31/565;A61P5/26;A61P5/34;

  • 国家 PE

  • 入库时间 2022-08-22 00:43:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号